Communities

People & Pages

Collections

Post has attachment

Post has attachment

Post has attachment
By the time ovarian cancer is diagnosed, most patients are at an advanced stage. Genentech’s #Avastin is now approved for advanced ovarian cancer, along with chemotherapy, to extend a woman’s survival. Merck’s #Keytruda is cleared to treat a type of B-cell lymphoma, and #moxidectin is only the second agent approved to treat river blindness. #Lithium and birth defects are explored in research, and finally, the #FDA lends some tips on medication safety to new parents.
Add a comment...

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Wait while more posts are being loaded